BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17953306)

  • 1. Depression in patients with Parkinson's disease: identification and treatment.
    Jamieson DR; Jamieson AE
    Br J Hosp Med (Lond); 2007 Sep; 68(9):485-8. PubMed ID: 17953306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depression in Parkinson's disease--Part 2: Therapy and management].
    Storch A; Schneider C; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
    Fortschr Neurol Psychiatr; 2010 Aug; 78(8):456-67. PubMed ID: 20694938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
    Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of depression and Parkinson's disease on cognitive functioning.
    Norman S; Tröster AI; Fields JA; Brooks R
    J Neuropsychiatry Clin Neurosci; 2002; 14(1):31-6. PubMed ID: 11884652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiety, depression, and psychosis in Parkinson's disease: unmet needs and treatment challenges.
    Chen JJ
    Neurol Clin; 2004 Oct; 22(3 Suppl):S63-90. PubMed ID: 15501367
    [No Abstract]   [Full Text] [Related]  

  • 7. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
    Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy.
    Chan-Palay V
    Adv Neurol; 1993; 60():438-46. PubMed ID: 8093581
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of depression in idiopathic Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S112-9. PubMed ID: 12211151
    [No Abstract]   [Full Text] [Related]  

  • 10. ECT for Parkinson's?
    Martin BA
    CMAJ; 2003 May; 168(11):1391-2; author reply 1392. PubMed ID: 12771059
    [No Abstract]   [Full Text] [Related]  

  • 11. Depression in Parkinson's disease: diagnosis and management.
    Latoo J; Mistry M; Dunne FJ
    Br J Hosp Med (Lond); 2012 Jun; 73(6):331-4. PubMed ID: 22875323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression in Parkinson's disease.
    Rihmer Z; Gonda X; Döme P
    Ideggyogy Sz; 2014 Jul; 67(7-8):229-36. PubMed ID: 25509363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Depressive symptoms and motor condition in Parkinson's disease patients].
    Stella F; Bucken-Gobbi LT; Gobbi S; Sant'Ana-Simões C
    Rev Neurol; 2007 Nov 16-30; 45(10):594-8. PubMed ID: 18008264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benchmarking in patient care: depression in Parkinson's disease].
    Spottke A; Schneider F; Dodel R
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):383-8. PubMed ID: 21767798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affect in Parkinson's disease: validation of the two-factor approach.
    Pourcher E; Rémillard S; Cohen H
    J Neurol Sci; 2010 Feb; 289(1-2):27-31. PubMed ID: 19747694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and management of depression in nursing facility residents.
    Kallenbach LE; Rigler SK
    J Am Med Dir Assoc; 2006 Sep; 7(7):448-55. PubMed ID: 16979091
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology of major depression in Belgian parkinsonian patients.
    Vanderheyden JE; Gonce M; Bourgeois P; Cras P; De Nayer AR; Flamez A; Supiot F; Donneau AF; Albert A; Berlaimont V;
    Acta Neurol Belg; 2010 Jun; 110(2):148-56. PubMed ID: 20873444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Depression in Parkinson's disease].
    Defebvre L
    Presse Med; 2009 Jun; 38(6):869-71. PubMed ID: 19162435
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety.
    Calleo J; Williams JR; Amspoker AB; Swearingen L; Hirsch ES; Anderson K; Goldstein SR; Grill S; Lehmann S; Little JT; Margolis RL; Palanci J; Pontone GM; Weiss H; Rabins P; Marsh L
    J Parkinsons Dis; 2013; 3(4):603-8. PubMed ID: 24275604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.